Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new ...

Researchers have developed a chip that analyzes a patient’s blood for cells shed by a lung cancer tumor, enabling treating physicians to determine whether lung cancer treatment is working by as early ...

Imec teamed up with the KU Leuven laboratory of tumor immunology and immunotherapy for the first clinical validation of its cell sorter chip technology. The chip successfully identified PD-1 positive ...

In a stride toward enhancing cancer treatment, University of Birmingham researchers are using organ-on-a-chip technology to imitate the liver's environment and improve immunotherapy for liver cancer.

(BOSTON) — Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely ...

Predicting cancer progression Shruti Jolly (left) delivers a patient blood sample to Sunitha Nagrath (right) to analyse. Their recent study showed that Nagrath's GO chips can help clinicians determine ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Design by Michelle Peng.Buy this photo. Researchers used the graphene oxide microfluidic chip to ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely on ...

Please provide your email address to receive an email when new articles are posted on . A miniature, three-dimensional heart model, called the “heart-on-a-chip,” successfully used reprogrammed stem ...